179 related articles for article (PubMed ID: 10591536)
1. Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants.
Jovanovic V; Guan HC; Van Tol HH
Pharmacogenetics; 1999 Oct; 9(5):561-8. PubMed ID: 10591536
[TBL] [Abstract][Full Text] [Related]
2. [35S]GTPgammaS binding at the human dopamine D4 receptor variants hD4.2, hD4.4 and hD4.7 following stimulation by dopamine, epinephrine and norepinephrine.
Czermak C; Lehofer M; Liebmann PM; Traynor J
Eur J Pharmacol; 2006 Feb; 531(1-3):20-4. PubMed ID: 16423344
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes.
Asghari V; Schoots O; van Kats S; Ohara K; Jovanovic V; Guan HC; Bunzow JR; Petronis A; Van Tol HH
Mol Pharmacol; 1994 Aug; 46(2):364-73. PubMed ID: 8078498
[TBL] [Abstract][Full Text] [Related]
4. I. NGD 94-1: identification of a novel, high-affinity antagonist at the human dopamine D4 receptor.
Tallman JF; Primus RJ; Brodbeck R; Cornfield L; Meade R; Woodruff K; Ross P; Thurkauf A; Gallager DW
J Pharmacol Exp Ther; 1997 Aug; 282(2):1011-9. PubMed ID: 9262370
[TBL] [Abstract][Full Text] [Related]
5. SH3 binding domains in the dopamine D4 receptor.
Oldenhof J; Vickery R; Anafi M; Oak J; Ray A; Schoots O; Pawson T; von Zastrow M; Van Tol HH
Biochemistry; 1998 Nov; 37(45):15726-36. PubMed ID: 9843378
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of a human dopamine D4 receptor expressed in HEK293 cells.
Lawson CF; Mortimore RA; Schlachter SK; Smith MW
Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):303-7. PubMed ID: 7934308
[TBL] [Abstract][Full Text] [Related]
7. (Aryloxy)alkylamines as selective human dopamine D4 receptor antagonists: potential antipsychotic agents.
Unangst PC; Capiris T; Connor DT; Doubleday R; Heffner TG; MacKenzie RG; Miller SR; Pugsley TA; Wise LD
J Med Chem; 1997 Dec; 40(25):4026-9. PubMed ID: 9406594
[TBL] [Abstract][Full Text] [Related]
8. Multiple dopamine D4 receptor variants in the human population.
Van Tol HH; Wu CM; Guan HC; Ohara K; Bunzow JR; Civelli O; Kennedy J; Seeman P; Niznik HB; Jovanovic V
Nature; 1992 Jul; 358(6382):149-52. PubMed ID: 1319557
[TBL] [Abstract][Full Text] [Related]
9. Functional activation by central monoamines of human dopamine D(4) receptor polymorphic variants coupled to GIRK channels in Xenopus oocytes.
Wedemeyer C; Goutman JD; Avale ME; Franchini LF; Rubinstein M; Calvo DJ
Eur J Pharmacol; 2007 May; 562(3):165-73. PubMed ID: 17350612
[TBL] [Abstract][Full Text] [Related]
10. Expression and characterization of a dopamine D4R variant associated with delusional disorder.
Zenner MT; Nobile M; Henningsen R; Smeraldi E; Civelli O; Hartman DS; Catalano M
FEBS Lett; 1998 Jan; 422(2):146-50. PubMed ID: 9489994
[TBL] [Abstract][Full Text] [Related]
11. Cryptic initiation at the human D4 receptor reveals a functional role for the amino terminus.
Schoots O; Sanyal S; Guan HC; Jovanovic V; Van Tol HH
Biochemistry; 1996 Mar; 35(11):3614-8. PubMed ID: 8639513
[TBL] [Abstract][Full Text] [Related]
12. Influence of the antipsychotic drug pipamperone on the expression of the dopamine D4 receptor.
Van Craenenbroeck K; Gellynck E; Lintermans B; Leysen JE; Van Tol HH; Haegeman G; Vanhoenacker P
Life Sci; 2006 Dec; 80(1):74-81. PubMed ID: 16978659
[TBL] [Abstract][Full Text] [Related]
13. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
Heinrich JN; Brennan J; Lai MH; Sullivan K; Hornby G; Popiolek M; Jiang LX; Pausch MH; Stack G; Marquis KL; Andree TH
Eur J Pharmacol; 2006 Dec; 552(1-3):36-45. PubMed ID: 17056032
[TBL] [Abstract][Full Text] [Related]
14. [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor.
Moreland RB; Terranova MA; Chang R; Uchic ME; Matulenko MA; Surber BW; Stewart AO; Brioni JD
Eur J Pharmacol; 2004 Aug; 497(2):147-54. PubMed ID: 15306199
[TBL] [Abstract][Full Text] [Related]
15. The dopamine D4 receptors and mechanisms of antipsychotic atypicality.
Wong AH; Van Tol HH
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1091-9. PubMed ID: 14642969
[TBL] [Abstract][Full Text] [Related]
16. A new approach to finding specific dopamine D4 receptor agonists.
Morishita H; Shibata K; Sakata N; Kita S; Katsuragi T
Eur J Pharmacol; 2005 Jun; 516(2):145-50. PubMed ID: 15922324
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D4-like receptors in vertebrate retina: does the retina offer a model for the D4-receptor analysis?
Zawilska JB; Nowak JZ
Pol J Pharmacol; 1997 Aug; 49(4):201-11. PubMed ID: 9437763
[TBL] [Abstract][Full Text] [Related]
18. The human dopamine D4 receptor repeat sequences modulate expression.
Schoots O; Van Tol HH
Pharmacogenomics J; 2003; 3(6):343-8. PubMed ID: 14581929
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional characteristics of the dopamine D4 receptor.
Van Tol HH
Adv Pharmacol; 1998; 42():486-90. PubMed ID: 9327945
[No Abstract] [Full Text] [Related]
20. [Functional role of dopamine D4 receptor in schizophrenia].
Semba J
Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb; 24(1):13-20. PubMed ID: 15027326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
